Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,747.12
(
0.71%
)
US TECH 100
24,193.40
(
0.74%
)
Dow Jones
47,308.79
(
0.77%
)
Brent Oil
100.18
(
1.91%
)
Bitcoin
73,623.78
(
-1.63%
)
News Focus
News Focus
Post# of 257251
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122790
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biomaven0 post# 113845

Tuesday, 02/01/2011 11:50:34 PM

Tuesday, February 01, 2011 11:50:34 PM

Post# of 257251
The Tarceva giveback was sui generis insofar as PFE had no say in the matter (if they wanted to close the Pharmacia merger). PFE may now opt to terminate some drug-development collaborations with small biotech companies, but I don’t think we should expect them to leave significant money on the table.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now